FUTURE study

JRCT ID: jRCTs052210149

Registered date:07/01/2022

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Unruptured cerebral aneurysm
• Date of first enrollment: 12/09/2022
• Target sample size: 300
• Study type: Interventional
• Intervention(s): Blood test

Outcome(s)

• Primary Outcome: Cut-off values for ADP-MA and ADP-inhibition% for the incidence rate of symptomatic stroke
• Secondary Outcome: Symptomatic ischemic stroke, high signal on diffusion-weighted images, hemorrhagic stroke

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

1) Over 20 years old and more at the time of consent acquisition
2) Patients planning to undergo Flow diverter placement for unruptured cerebral aneurysm
3) Patients who have been taking or are scheduled to take aspirin and clopidogrel for more than 5 days before procedure
4) Patients with written consent

Exclude criteria

1) Patients planning to change the content of antiplatelet drugs on the day of procedure
2) Patients on warfarin or direct oral anticoagulant (DOAC)
3) Patients contraindicated for MRI examination

Related Information

• Primary Sponsor: Imamura Hirotoshi
• Source(s) of Monetary Support: HAEMONETICS CORP.